{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:51:41Z","timestamp":1767801101325,"version":"3.49.0"},"reference-count":54,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023233","name":"National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["NIHR202733"],"award-info":[{"award-number":["NIHR202733"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Exeter Biomedical Research Centre"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,11,19]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The first objective was to establish the feasibility of conducting a definitive trial to evaluate the effectiveness of mobility and strength training with or without protein supplements for pre-frail\/frail older people with low protein intake. The second objective was to finalise outcome measures for a definitive trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicentre feasibility randomised controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and participants<\/jats:title>\n                    <jats:p>Four National Health Service (NHS) community trust physiotherapy departments. We recruited via clinical caseloads, an existing cohort study and community advertising. Participants were adults aged \u226560 years, frail or pre-frail, reporting walking difficulties or slow walking and low protein intake (&lt;1\u2009g protein\/kg of body weight (kgBW)\/day). The recruitment target was 50 participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>All participants undertook two times a week mobility and strength training supported by a physiotherapist for 24\u2009weeks. Half of the participants were randomised (1:1) to receive 24\u2009weeks of daily protein supplements to increase protein intake up to 1.6\u2009g\/kgBW\/day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary feasibility objectives<\/jats:title>\n                    <jats:p>Feasibility outcomes assessed recruitment, intervention fidelity, adherence, tolerance and study retention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Secondary objectives<\/jats:title>\n                    <jats:p>We assessed clinical data collection at baseline and 5\u20138\u2009month follow-up including the short physical performance battery (SPPB), 6\u2009min walk test (6MWT) and participant-reported outcomes. Outcome assessors were blinded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical methods<\/jats:title>\n                    <jats:p>All participants were analysed in the groups as randomised provided they were not withdrawn from the study before their treatment started and contributed outcome data (modified intention to treat). Our primary feasibility and secondary outcome measures were summarised using descriptive statistics such as mean and SD, median and IQR or counts with percentages. Secondary objectives were exploratory, and mean between group differences at follow-up were estimated for each continuous outcome using linear regression models adjusted for baseline outcome score and frailty status, and presented with associated 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Initially, recruitment focused on existing caseloads, but patients were more unwell and disabled than anticipated and ineligible. No participants were recruited from the cohort. A community recruitment strategy was implemented. We screened 952 older adults and 20 participants were randomised. We ran out of time to reach our target.<\/jats:p>\n                    <jats:p>We achieved good intervention fidelity for both interventions. The median number of exercise sessions completed was 10.5\/16 (IQR 7\u201313). Six participants received supplements which they tolerated well and took regularly. 14 participants (70%) attended follow-up assessments with no difference in retention between arms.<\/jats:p>\n                    <jats:p>The median age of participants was 76 years (IQR 68.5\u201380.0) and 15\/20 (75%) were frail. All clinical outcomes showed a trend towards larger improvements in the exercise and protein arm, but these were not statistically significant. For example, SPPB scores (mean difference 0.93, 95% CI (\u22122.70 to 4.56)) and 6MWT (mean difference 41.92 m, 95% CI (\u221239.05 to 122.89)) were both higher in the exercise and protein arm compared to control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study was not feasible based on the original protocol. Recruitment was the biggest challenge. We established a more efficient route to recruitment (community advertising) which requires further refinement. Clinical outcomes consistently favoured the exercise and protein group, which should be interpreted cautiously but suggest this question is worthy of further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN30405954\">ISRCTN30405954<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-102411","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:40:41Z","timestamp":1767789641000},"page":"e102411","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Mobility and strength training with and without protein supplements for pre-frail\/frail older people with low protein intake: maximising mobility and strength training (MMoST) feasibility randomised controlled trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"isrctn30405954","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0638-0406","authenticated-orcid":false,"given":"Esther","family":"Williamson","sequence":"first","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"},{"name":"Public Health and Sport Sciences, University of Exeter, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Biggin","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Morris","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana R","family":"Marian","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Mwema","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Carver","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement Representative, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Elizabeth","family":"Lamb","sequence":"additional","affiliation":[{"name":"Public Health and Sport Sciences, University of Exeter, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"2026010704403001000_16.1.e102411.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62167-9"},{"key":"2026010704403001000_16.1.e102411.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2010.08.009"},{"key":"2026010704403001000_16.1.e102411.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.05.021"},{"key":"2026010704403001000_16.1.e102411.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2014.04.007"},{"key":"2026010704403001000_16.1.e102411.5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/jcsm.12580","article-title":"Prevalence of protein intake below recommended in community-dwelling older adults: a meta-analysis across cohorts from the PROMISS consortium","volume":"11","author":"Hengeveld","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026010704403001000_16.1.e102411.6","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-019-1273-z"},{"key":"2026010704403001000_16.1.e102411.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228821","article-title":"Primary care interventions to address physical frailty among community-dwelling adults aged 60 years or older: A meta-analysis","volume":"15","author":"Macdonald","year":"2020","journal-title":"PLoS One"},{"key":"2026010704403001000_16.1.e102411.8","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092820","article-title":"Nutritional Intervention to Prevent the Functional Decline in Community-Dwelling Older Adults: A Systematic Review","volume":"12","author":"Mareschal","year":"2020","journal-title":"Nutrients"},{"key":"2026010704403001000_16.1.e102411.9","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqy192"},{"key":"2026010704403001000_16.1.e102411.10","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-018-1139-9"},{"key":"2026010704403001000_16.1.e102411.11","unstructured":"NICE . NICE CG161: Falls: assessment and prevention of falls in older people. Excellence NIoHaC; 2013."},{"key":"2026010704403001000_16.1.e102411.12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.physio.2019.01.019","article-title":"Development and delivery of the BOOST (Better Outcomes for Older adults with Spinal Trouble) intervention for older adults with neurogenic claudication","volume":"105","author":"Ward","year":"2019","journal-title":"Physiotherapy"},{"key":"2026010704403001000_16.1.e102411.13","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/gerona\/glac063","article-title":"The Clinical Effectiveness of a Physiotherapy Delivered Physical and Psychological Group Intervention for Older Adults With Neurogenic Claudication: The BOOST Randomized Controlled Trial","volume":"77","author":"Williamson","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026010704403001000_16.1.e102411.14","doi-asserted-by":"crossref","DOI":"10.3310\/nihropenres.13507.1","article-title":"Mobility and strength training with and without protein supplements for pre-frail or frail older adults with low protein intake: the Maximising Mobility and Strength Training (MMoST) feasibility randomised controlled trial protocol","volume":"3","author":"Biggin","year":"2023","journal-title":"NIHR Open Res"},{"key":"2026010704403001000_16.1.e102411.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2026010704403001000_16.1.e102411.16","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"2026010704403001000_16.1.e102411.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037516","article-title":"Cohort profile: Oxford Pain, Activity and Lifestyle (OPAL) Study, a prospective cohort study of older adults in England","volume":"10","author":"Sanchez Santos","year":"2020","journal-title":"BMJ Open"},{"key":"2026010704403001000_16.1.e102411.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196406","article-title":"Development and validation of a short food questionnaire to screen for low protein intake in community-dwelling older adults: The Protein Screener 55+ (Pro55+)","volume":"13","author":"Wijnhoven","year":"2018","journal-title":"PLoS One"},{"key":"2026010704403001000_16.1.e102411.19","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/3.3.152"},{"key":"2026010704403001000_16.1.e102411.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-018-1113-8","article-title":"Validity of an online 24-h recall tool (myfood24) for dietary assessment in population studies: comparison with biomarkers and standard interviews","volume":"16","author":"Wark","year":"2018","journal-title":"BMC Med"},{"key":"2026010704403001000_16.1.e102411.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-097608"},{"key":"2026010704403001000_16.1.e102411.22","unstructured":"Todorovic V , Mafrici B , eds. A pocket guide to nutrition. In: British dietetic association. 2018."},{"key":"2026010704403001000_16.1.e102411.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.016"},{"key":"2026010704403001000_16.1.e102411.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013537","article-title":"Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies","volume":"7","author":"Avery","year":"2017","journal-title":"BMJ Open"},{"key":"2026010704403001000_16.1.e102411.25","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-023-01291-5","article-title":"Recommendations for progression criteria during external randomised pilot trial design, conduct, analysis and reporting","volume":"9","author":"Mellor","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"2026010704403001000_16.1.e102411.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-13832-3","article-title":"The effectiveness of the Healthworks Staying Steady community-based falls prevention exercise programme to improve physical function in older adults: a 6-year service evaluation","volume":"22","author":"James","year":"2022","journal-title":"BMC Public Health"},{"key":"2026010704403001000_16.1.e102411.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020576","article-title":"Geriatrician-led evidence-based Falls Prevention Clinic: a prospective 12-month feasibility and acceptability cohort study among older adults","volume":"8","author":"Davis","year":"2018","journal-title":"BMJ Open"},{"key":"2026010704403001000_16.1.e102411.28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ptj\/pzaa006","article-title":"What Really Works in Intervention? Using Fidelity Measures to Support Optimal Outcomes","volume":"100","author":"An","year":"2020","journal-title":"Phys Ther"},{"key":"2026010704403001000_16.1.e102411.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015452","article-title":"Using mixed methods to assess fidelity of delivery and its influencing factors in a complex self-management intervention for people with osteoarthritis and low back pain","volume":"7","author":"Toomey","year":"2017","journal-title":"BMJ Open"},{"key":"2026010704403001000_16.1.e102411.30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1017\/S0007114519001831","article-title":"Protein supplementation combined with low-intensity resistance training in geriatric medical patients during and after hospitalisation: a randomised, double-blind, multicentre trial","volume":"122","author":"Gade","year":"2019","journal-title":"Br J Nutr"},{"key":"2026010704403001000_16.1.e102411.31","first-page":"7","article-title":"Loss to follow-up","volume":"2","author":"Dettori","year":"2011","journal-title":"Evid Based Spine Care J"},{"key":"2026010704403001000_16.1.e102411.32","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-15-264","article-title":"Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study","volume":"15","author":"Teare","year":"2014","journal-title":"Trials"},{"key":"2026010704403001000_16.1.e102411.33","doi-asserted-by":"crossref","DOI":"10.1007\/s40520-023-02652-z","article-title":"Barriers and facilitators to older adult participation in intergenerational physical activity program: a systematic review","volume":"36","author":"Zhou","year":"2024","journal-title":"Aging Clin Exp Res"},{"key":"2026010704403001000_16.1.e102411.34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.22540\/JFSF-03-105","article-title":"Enablers and barriers to older people\u2019s participation in strength and balance activities: A review of reviews","volume":"3","author":"Cavill","year":"2018","journal-title":"J. Frailty Sarcopenia Falls"},{"key":"2026010704403001000_16.1.e102411.35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/LLBX6901","article-title":"Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT","volume":"9","author":"Witham","year":"2022","journal-title":"Efficacy Mech Eval"},{"key":"2026010704403001000_16.1.e102411.36","doi-asserted-by":"crossref","DOI":"10.3390\/nu16183053","article-title":"Resistance Training and Nutritional Supplementation in Older Adults with Sarcopenia after Acute Disease: A Feasibility Study","volume":"16","author":"Meza-Valderrama","year":"2024","journal-title":"Nutrients"},{"key":"2026010704403001000_16.1.e102411.37","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2023.112128","article-title":"Health maintenance through home-based interventions for community-dwelling older people with sarcopenia during and after the COVID-19 pandemic: A systematic review and meta-analysis","volume":"174","author":"Li","year":"2023","journal-title":"Exp Gerontol"},{"key":"2026010704403001000_16.1.e102411.38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/ajcn\/nqaa449","article-title":"Does supplementation with leucine-enriched protein alone and in combination with fish-oil-derived n-3 PUFA affect muscle mass, strength, physical performance, and muscle protein synthesis in well-nourished older adults? A randomized, double-blind, placebo-controlled trial","volume":"113","author":"Murphy","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"2026010704403001000_16.1.e102411.39","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnt075"},{"key":"2026010704403001000_16.1.e102411.40","first-page":"142","article-title":"Role of muscle-targeted nutritional therapy: new data","volume":"25","author":"Cereda","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2026010704403001000_16.1.e102411.41","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092607","article-title":"Effectiveness of Protein Supplementation Combined with Resistance Training on Muscle Strength and Physical Performance in Elderly: A Systematic Review and Meta-Analysis","volume":"12","author":"Labata-Lezaun","year":"2020","journal-title":"Nutrients"},{"key":"2026010704403001000_16.1.e102411.42","doi-asserted-by":"crossref","DOI":"10.2340\/jrm.v56.18628","article-title":"Normative values in healthy adults for the 6-minute and 2-minute walk tests in Belgium and Vietnam: implications for clinical practice","volume":"56","author":"Nguyen","year":"2024","journal-title":"J Rehabil Med"},{"key":"2026010704403001000_16.1.e102411.43","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/55.4.M221"},{"key":"2026010704403001000_16.1.e102411.44","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.1002\/acr.20538","article-title":"Measures of Physical Performance Assessments","volume":"63","author":"Bennell","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026010704403001000_16.1.e102411.45","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afr051"},{"key":"2026010704403001000_16.1.e102411.46","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8194537","article-title":"Considerations and Practical Options for Measuring Muscle Strength: A Narrative Review","volume":"2019","author":"Bohannon","year":"2019","journal-title":"Biomed Res Int"},{"key":"2026010704403001000_16.1.e102411.47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026010704403001000_16.1.e102411.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2009.11.003"},{"key":"2026010704403001000_16.1.e102411.49","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ageing\/afab006","article-title":"A classification tree to assist with routine scoring of the Clinical Frailty Scale","volume":"50","author":"Theou","year":"2021","journal-title":"Age Ageing"},{"key":"2026010704403001000_16.1.e102411.50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.archger.2017.11.009","article-title":"Substitution of Fried\u2019s performance-based physical frailty criteria with self-report questions","volume":"75","author":"Op Het Veld","year":"2018","journal-title":"Arch Gerontol Geriatr"},{"key":"2026010704403001000_16.1.e102411.51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53455.x"},{"key":"2026010704403001000_16.1.e102411.52","doi-asserted-by":"publisher","DOI":"10.1016\/0003-6870(87)90010-X"},{"key":"2026010704403001000_16.1.e102411.53","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000163658.65008.ec"},{"key":"2026010704403001000_16.1.e102411.54","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-12-74","article-title":"Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population","volume":"12","author":"Agborsangaya","year":"2014","journal-title":"Health Qual Life Outcomes"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-102411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:40:45Z","timestamp":1767789645000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-102411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,7]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjopen-2025-102411"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-102411","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}